Lexicon Pharmaceuticals, Inc. Common Stock Quote & Summary Data
Edit Symbol List
Enter up to 25 symbols separated by commas or spaces in the text box below. These symbols will be available during your session for use on applicable pages.
Don’t know the stock symbol? Use the Symbol Lookup tool.
Alphabetize the sort order of my symbols
Investing just got easier
Sign up now to become a NASDAQ.com member and begin receiving instant notifications when key events occur that affect the stocks you follow.
“Best Ask” is the lowest price currently being asked for a block of stock.
“Today’s Low” The lowest sales price the stock has fallen to during the regular trading hours, the intra-day low.
“52 Week Low” is the lowest sales price the stock has fallen to during the regular trading hours during the most recent 52 week period.
Prices during the When Issued trading period are used in the 52 week high/low calculation.
Company Description (as filed with the SEC)
Lexicon Pharmaceuticals is a biopharmaceutical company focused on the development and commercialization of breakthrough treatments for human disease. We are presently devoting most of our resources to the commercialization or development of our four most advanced drug programs: * We have obtained approval from the U.S. Food and Drug Administration, or FDA, to sell our first commercial product, XERMELO(TM) (telotristat ethyl), an orally-delivered small molecule drug for the treatment of carcinoid syndrome diarrhea in combination with somatostatin analog, or SSA, therapy in adults inadequately controlled by SSA therapy. We have commenced sales and marketing of XERMELO, and it is now commercially available to patients in the United States. . More .
Where does LXRX fit in the risk graph?